Karvellas et al correlated survival with the serum concentration of FABP1 in patients with acetaminophen-associated acute liver failure. Serum concentrations of FABP1 can help to identify patients who may require moer aggressive management such as hepatic transplantation. The authors are from the U.S. Acute Liver Failure Study Group (ALFSG)